Acceptability of contraceptive implants at the maternity ward of the Matam Communal Medical Center
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20220158Keywords:
Implant, Contraception, Effectiveness, SatisfactionAbstract
Background: World Health Organization (WHO), defines contraception as "the use of agents, devices, methods or procedures to decrease the likelihood of conception or avoid it". In Africa, only 24% of women of childbearing age have access to a modern contraceptive method. The objective of the study was to determine the frequency of use of the contraceptive implant, to describe the socio-demographic characteristics of the users, to identify the reasons for the choice of the method and to assess the degree of satisfaction of the clients.
Methods: The study was conducted at the Matam Communal Medical Center on level 2 of the health pyramid in Guinea. This was a 12-month cross-sectional, descriptive and analytical study (June 2017 to May 2018), including all women admitted for desire for contraception and who agreed to choose the implant as a contraceptive method.
Results: The study involved 512 clients. The proportion of female users was 26.21%. The average age was 27.8 years, the main users were women of liberal trade, married, multiparous. The main reasons for choice cited by clients were the effectiveness and long duration of action of the method, i.e. 35.2% and 30.9% respectively. The majority of providers of the method were represented by midwives (73.3%) and the degree of client satisfaction with the method was 97%.
Conclusions: The implant is a long-acting method of contraction. It is frequently used at the Communal Medical Center of Matam. Its efficient use would involve effective counselling.
References
Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Family planning: the unfinished agenda. Geneva. Lancet. 2006;368(9549):1810-27.
Hubacher D, Spector H, Monteith C, Chen P-L, Hart C. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods : a randomized patient preference trial. Am J Obstet Gynecol. Févr. 2017;216(2):101‑9.
Yalew SA, Zeleke BM, Teferra AS. Demand for long acting contraceptive methods and associated factors among family planning service users, Northwest Ethiopia: a health facility based cross sectional study. BMC Res Notes. 2015;8(29):10.
Vu LTH, Oh J, Bui QTT, Le ATK. Use of modern contraceptives among married women in Vietnam: a multilevel analysis using the Multiple Indicator Cluster Survey (2011) and the Vietnam Population and Housing Census (2009). Glob Health Action. 2016;9(10):3402.
Jenny AH, Renée D, Kramer, Kristin M, Ryder. Provider bias in long-acting reversible contraception (LARC) promotion and removal: perceptions of young adult women. Am J Santé publique . 2016;106(11):1932-7.
Zeal C, Jenny A, Higgins, Shaunna R, Newton. Patient-perceived autonomy and long-acting reversible contraceptive use: a qualitative assessment in a midwestern, university CommunityBioResearch open access. 2018;7(1):25-32.
Reiss K, Penfold S, Alabi O, Ali M, Hopkins K, Ngo TD, et al. Safety, Quality, and Acceptability of Contraceptive Subdermal Implant Provision by Community Health Extension Workers Versus Nurses and Midwives in Nigeria: Protocol for a Quasi-Experimental, Noninferiority Study. JMIR Res Protoc. 2018;7(3):67.
Ministry of Health and Public Hygiene. National Directorate of Family Health and Nutrition. National Action Plan for Repositioning Family Planning in Guinea 2014-2018.
National Institute of Statistics (NIS) and ICF. 2018. Guinea Demographic and Health Survey 2018. Conakry, Guinea, and Rockville, Maryland, USA: INS and ICF.
Beesham I, J Smit, M Beksinska, M Panday, Makatini V. Reasons for requesting removal of the hormonal implant, Implanon NXT, at an urban reproductive health clinic in KwaZulu-Natal, South Africa. 2019;109(10):750-5.
Ntambue MA, Tshiala RN, Malonga FK, Ilunga TM, Kamonayi JM, Kazadi ST et al. Use of modern contraceptive methods in the Democratic Republic of Congo: prevalence and barriers in the Dibindi health zone in Mbuji-Mayi Pan African Medical Journal. 2016;26:199.
Koné B, Lankoande J, Ouédraogo MR, Ouédraogo A, Bonane B, Touré B et al. Contraception with subcutaneous levonorgestrel implants (Norplant®): African experience in Burkina Faso. Méd Afr Noire 1999;46(3):136-9.
Namuunda M, Bakibinga P. The effect of joint contraceptive decisions on theuse of Injectables, Long-Acting and Permanent methods (ILAPMs) amongmarriedfemale (15–49) contraceptive users in Zambia: a cross-sectional study. Reproductive Health. 2014;51:1-8.
Mamadou K, Fomba S, Tall S, Alou S, Mamadou D, Djoukou KN et al. L’Utilisation des Méthodes Contraceptives Modernes au Centre de Santé de Référence de la Commune VI du District de Bamako. Health Sci Dis. 2020;21(10):82-6.
Mutombo N, Bakibinga P. The effect of joint contraceptive decisions on these of Injectables, Long-Acting and Permanent methods (ILAPMs) amongmarriedfemale (15–49) contraceptive users in Zambia : a cross-sectional study. Reproductive Health. 2014;11:51.
Arribas-Mir L, Rueda-Lozano D, Agrela-Cardona M, Cedeno-Benavides T, Olvera-Porcel C, Bueno-Cavanillas A. Insertion et expérience de suivi de 3ans de 372 implants contraceptifs sous cutanés d’étonogestrel par des médecins de famille à Grenade Espagne. 2009 ;80(5):457-62.
Sergent F, Clamogeran C, Bastard AM, Verspyck E, Marpeau L. Acceptability of the contraceptive implant containing Etonogestrel (Implanon). J Gynecol Obstet Biol Reprod Paris. 2004;33(5):407-15.
Martin C, Tanguy M, Aspeele F, Fanello S. Tolerance of the contraceptive implant by prescription context (after abortion or not): Prospective study on 127 consultants. J Gynecol Obstet Biol Reprod (Paris). 2010;39(8):632-6.
Ralisata L, Ravolamanana, Randaoharison PG, Razafintsalama DL. Contraception with subcutaneous levonorgestrel implants (Norplant®) at the University Hospital of Mahajanga Madagascar. Médecine d'Afrique Noire. 2000;47(10):410-5.
